Publications by authors named "C T A Evelo"

Background: Inclusion Body Myositis is an acquired muscle disease. Its pathogenesis is unclear due to the co-existence of inflammation, muscle degeneration and mitochondrial dysfunction. We aimed to provide a more advanced understanding of the disease by combining multi-omics analysis with prior knowledge.

View Article and Find Full Text PDF

Rare diseases may affect the quality of life of patients and be life-threatening. Therapeutic opportunities are often limited, in part because of the lack of understanding of the molecular mechanisms underlying these diseases. This can be ascribed to the low prevalence of rare diseases and therefore the lower sample sizes available for research.

View Article and Find Full Text PDF

Systems biology aims to understand living organisms through mathematically modeling their behaviors at different organizational levels, ranging from molecules to populations. Modeling involves several steps, from determining the model purpose to developing the mathematical model, implementing it computationally, simulating the model's behavior, evaluating, and refining the model. Importantly, model simulation results must be reproducible, ensuring that other researchers can obtain the same results after writing the code de novo and/or using different software tools.

View Article and Find Full Text PDF
Article Synopsis
  • The VHP4Safety project aims to create a Virtual Human Platform (VHP) that shifts safety assessments of chemicals and pharmaceuticals from animal testing to human-based methods, enhancing human health protection.
  • The project involves collaboration among academic, regulatory, industrial, and societal partners and focuses on three main research areas: building the VHP, incorporating human data, and implementing the platform through real-world case studies.
  • By combining innovative technology and stakeholder engagement through events like designathons, the project seeks to develop new methodologies for safety assessments while eliminating the need for animal testing.
View Article and Find Full Text PDF

Due to its involvement in physiological and pathological processes, histone deacetylase 6 (HDAC6) is considered a promising pharmaceutical target for several neurological manifestations. However, the exact regulatory role of HDAC6 in the central nervous system (CNS) is still not fully understood. Hence, using a semi-automated literature screening technique, we systematically collected HDAC6-protein interactions that are experimentally validated and reported in the CNS.

View Article and Find Full Text PDF